Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Gastrointestinal 8 Tumor-Agnostic 4 Genitourinary 4 Head & Neck 3 Gynecologic 2 Thoracic 1 Lymphoid 1 Endocrine 1 Dermatologic 1 CNS 1

Conditions

Patient Participation 1 Melanoma 1

Interventions

Blood Specimen Collection 16 Cyclophosphamide 11 fludarabine phosphate 10 Peripheral Blood Stem Cell Transplantation 10 Cyclosporine 10 Photochemotherapy 9 Biopsy 9 Whole-Body Irradiation 8 Standard of Care 8 Radiotherapy 8 Educational Status 8 Surgical Procedures, Operative 7 Radiosurgery 7 Mycophenolic Acid 7 Early Intervention, Educational 7 Aminolevulinic Acid 7 Tomography, Optical Coherence 6 Surveys and Questionnaires 6 Psychiatric Rehabilitation 6 Practice Guidelines as Topic 6 Methods 6 Melphalan 6 Filgrastim 6 Sentinel Lymph Node Biopsy 5 Magnetic Resonance Spectroscopy 5 Busulfan 5 Antilymphocyte Serum 5 methyl 5-aminolevulinate 4 Therapeutics 4 Observation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Decision Support Techniques × Dermatologic × Clear all

NCT04240717 2022-11-07

PEF-Immun

University Hospital Heidelberg

Phase NA Completed

Melanoma, Patient Participation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡